Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Development of a Vaccine against Human Cytomegalovirus: Advances, Barriers, and Implications for the Clinical Practice
Sara Scarpini, Francesca Morigi, Ludovica Betti, et al.
Vaccines (2021) Vol. 9, Iss. 6, pp. 551-551
Open Access | Times Cited: 63

Showing 1-25 of 63 citing articles:

A systematic literature review of the global seroprevalence of cytomegalovirus: possible implications for treatment, screening, and vaccine development
Karen B. Fowler, Jacek Mucha, Monika Neumann, et al.
BMC Public Health (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 164
Lipid nanoparticles for delivery of RNA therapeutics: Current status and the role of in vivo imaging
Han Na Jung, Seok‐Yong Lee, Somin Lee, et al.
Theranostics (2022) Vol. 12, Iss. 17, pp. 7509-7531
Open Access | Times Cited: 116
mRNA vaccines for COVID-19 and diverse diseases
Abid Hussain, Haiyin Yang, Jun Zhang, et al.
Journal of Controlled Release (2022) Vol. 345, pp. 314-333
Open Access | Times Cited: 83
The mRNA-1647 vaccine: A promising step toward the prevention of cytomegalovirus infection (CMV)
Adewunmi Akingbola, Abiodun Adegbesan, Olajumoke Adewole, et al.
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access | Times Cited: 2
40 Years after the Registration of Acyclovir: Do We Need New Anti-Herpetic Drugs?
Anna Majewska, Beata Młynarczyk-Bonikowska
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3431-3431
Open Access | Times Cited: 67
Lipid nanoparticles: The game-changer in CRISPR-Cas9 genome editing
Arezoo Mohammadian Farsani, Negin Mokhtari, Saghi Nooraei, et al.
Heliyon (2024) Vol. 10, Iss. 2, pp. e24606-e24606
Open Access | Times Cited: 13
Human Cytomegalovirus (HCMV) Genetic Diversity, Drug Resistance Testing and Prevalence of the Resistance Mutations: A Literature Review
Ivana Grgić, Lana Gorenec
Tropical Medicine and Infectious Disease (2024) Vol. 9, Iss. 2, pp. 49-49
Open Access | Times Cited: 8
Immune Landscape of CMV Infection in Cancer Patients: From “Canonical” Diseases Toward Virus-Elicited Oncomodulation
Ranim El Baba, Georges Herbein
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 46
Congenital Cytomegalovirus and Hearing Loss: The State of the Art
Mirko Aldè, S. Binda, V. Prímache, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 13, pp. 4465-4465
Open Access | Times Cited: 21
SARS-CoV-2 vaccination in the first year after allogeneic hematopoietic cell transplant: a prospective, multicentre, observational study
Joshua A. Hill, Michael J. Martens, Jo‐Anne H. Young, et al.
EClinicalMedicine (2023) Vol. 59, pp. 101983-101983
Open Access | Times Cited: 20
Nanostructured Drug Delivery Systems in Immunotherapy: An Updated Overview of Nanotechnology-Based Therapeutic Innovations
George-Alexandru Croitoru, Adelina-Gabriela Niculescu, Dragoș Epistatu, et al.
Applied Sciences (2024) Vol. 14, Iss. 19, pp. 8948-8948
Open Access | Times Cited: 8
Vaccine delivery systems and administration routes: Advanced biotechnological techniques to improve the immunization efficacy
Abdellatif Bouazzaoui, Ahmed A. H. Abdellatif
Vaccine X (2024) Vol. 19, pp. 100500-100500
Open Access | Times Cited: 6
Structure-based design of a soluble human cytomegalovirus glycoprotein B antigen stabilized in a prefusion-like conformation
Madeline R. Sponholtz, Patrick O. Byrne, Alison G. Lee, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 37
Open Access | Times Cited: 6
An Update on Current Antiviral Strategies to Combat Human Cytomegalovirus Infection
Kingshuk Panda, Deepti Parashar, Rajlakshmi Viswanathan
Viruses (2023) Vol. 15, Iss. 6, pp. 1358-1358
Open Access | Times Cited: 15
Vaccine value profile for cytomegalovirus
Suresh B. Boppana, Michiel van Boven, William J. Britt, et al.
Vaccine (2023) Vol. 41, pp. S53-S75
Open Access | Times Cited: 13
Prospects and Challenges in Developing mRNA Vaccines for Infectious Diseases and Oncogenic Viruses
L. V. Simhachalam Kutikuppala, Islam Kourampi, Ramya S. D. Kanagala, et al.
Medical Sciences (2024) Vol. 12, Iss. 2, pp. 28-28
Open Access | Times Cited: 5
Lessons from Acquired Natural Immunity and Clinical Trials to Inform Next-Generation Human Cytomegalovirus Vaccine Development
Xintao Hu, Hsuan-Yuan Wang, Claire E. Otero, et al.
Annual Review of Virology (2022) Vol. 9, Iss. 1, pp. 491-520
Open Access | Times Cited: 22
Primary, Secondary, and Tertiary Prevention of Congenital Cytomegalovirus Infection
Pauline Sartori, Charles Egloff, Najeh Hcini, et al.
Viruses (2023) Vol. 15, Iss. 4, pp. 819-819
Open Access | Times Cited: 12
Congenital cytomegalovirus infection: the state of the art and future perspectives
Serena Salomè, F Corrado, Laura Letizia Mazzarelli, et al.
Frontiers in Pediatrics (2023) Vol. 11
Open Access | Times Cited: 12
Molecular mimicry in the pathogenesis of autoimmune rheumatic diseases
Michaela Fehringer, Thomas Vogl
Journal of Translational Autoimmunity (2025) Vol. 10, pp. 100269-100269
Open Access
Safety, Immunogenicity, and Efficacy of Cytomegalovirus Vaccines: A Systematic Review of Randomized Controlled Trials
Manuela Chiavarini, A Genga, G. Ricciotti, et al.
Vaccines (2025) Vol. 13, Iss. 1, pp. 85-85
Open Access
RNA-targeted proteomics identifies YBX1 as critical for efficient HCMV mRNA translation
Rebekah J. Dickmander, Erik M. Lenarcic, John D. Sears, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 10
Open Access
Nonhuman primate model mirroring human congenital cytomegalovirus infection reveals a spectrum of vertical transmission outcomes
Amitinder Kaur, Tabitha D. Manuel, Matilda J. Moström, et al.
(2025)
Closed Access
New Applications of Lipid and Polymer-Based Nanoparticles for Nucleic Acids Delivery
Adelina-Gabriela Niculescu, Alexandra Cătălina Bîrcă, Alexandru Mihai Grumezescu
Pharmaceutics (2021) Vol. 13, Iss. 12, pp. 2053-2053
Open Access | Times Cited: 26
Antiviral Approach to Cytomegalovirus Infection: An Overview of Conventional and Novel Strategies
Paolo Bottino, Lisa Pastrone, Antonio Curtoni, et al.
Microorganisms (2023) Vol. 11, Iss. 10, pp. 2372-2372
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top